Versantis raises CHF 4,4 million in series a financing to advance new generation of liver disease medicines

by Healthequity

Versantis, a pharmaceutical company focused on the development of products addressing a high unmet medical need in the diagnosis, prevention, and treatment of liver diseases, today announces the closi...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Citring closes a €920,000 funding roun...

by Faraday Venture Partners

Citring began operations in late 2017 and passed through Lanzadera, on...

Photos Stream